Min Zhu
Nanning, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Safety, Pharmacokinetics, and Efficacy of 1.5% Ruxolitinib Gel (HDM3010) in Adult Patients with Prurigo Nodularis: A Phase I/II, Randomized, Double-Blind, Vehicle-Controlled Multicenter Clinical Trial.
Journal: Dermatology and therapy
Published: April 10, 2026
Qianlong Shutong Formula alleviates benign prostatic hyperplasia associated with the regulation of inflammation, fibrosis and the Hippo-YAP/TAZ pathway.
Journal: Tissue & cell
Published: February 12, 2026
Mechanism of Qianlong Shutong Formula in the Treatment of Benign Prostatic Hyperplasia by Regulating Metabolism and Protein Function.
Journal: Biomedical chromatography : BMC
Published: January 09, 2026
Review of Chinese medicine intervention in PI3K/AKT pathway to regulate fibrosis.
Journal: Medicine
Published: July 15, 2025
The association between benign and malignant prostatic hyperplastic diseases and blood and urine biomarkers: A Mendelian randomization study.
Journal: Medicine
Published: March 11, 2025
Verification of Qianlong Shutong Formula in the Treatment of Benign Prostatic Hyperplasia.
Journal: Combinatorial chemistry & high throughput screening
Published: July 18, 2024
Research progress in the relationship of hypoxia-inducible factor 1 with prostate diseases in hypoxic environment
Journal: Zhonghua nan ke xue = National journal of andrology
Published: April 10, 2024
The relationship between circulating metabolites and prostate hyperplasia: a Mendelian randomization study.
Journal: Aging clinical and experimental research
Published: August 28, 2023
Analysis of genetic diversity and selection characteristics using the whole genome sequencing data of five buffaloes, including Xilin buffalo, in Guangxi, China.
Journal: Frontiers in genetics
Published: October 31, 2022
Impacts of the expressions of Fas and FasL mRNA and proteins on sperm concentration and motility
Journal: Zhonghua nan ke xue = National journal of andrology
Published: December 01, 2021
Based on network pharmacology and molecular docking to predict the mechanism of Huangqi in the treatment of castration-resistant prostate cancer.
Journal: PloS one
Published: June 26, 2021
Last Updated: 09/26/2026